Tuberc Respir Dis.
2004 Mar;56(3):315-320. 10.4046/trd.2004.56.3.315.
A Case of Drug Induced Interstitial Pneumonitis by Gemcitabine
- Affiliations
-
- 1Department of Internal Medicine, Inje University, Medical School, Korea.
- 2Department of Radiology, Inje University, Medical School, Korea.
- KMID: 2132959
- DOI: http://doi.org/10.4046/trd.2004.56.3.315
Abstract
- Gemcitabine is an effective newly developed chemotherapeutic agent, which is increasingly being used to treat non-small cell lung, ovarian and breast cancers. Pulmonary toxicity is usually self-limiting mild dyspnea, bronchospasm, but severe pulmonary toxicity is rarely reported. Herein, we report drug induced interstitial lung disease associated with gemcitabine treatment. High resolution computerized tomogram (HRCT) showed an increased ground glass opacity and thickened septal lines. The patient showed a rapid good response with prednisolone treatment.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Application of hypersensitivity skin testing in chemotherapy-induced pneumonitis
- A case of rifampicin-induced interstitial pneumonitis
- Successful Treatment of Interstitial Pneumonitis Induced by Leflunomide
- Rituximab-induced Interstitial Pneumonitis in a Young Patient: A Case Report and Review of the Literature
- A Good Outcome for a Case of Chronic Pneumonitis of Infancy
